0.00Open0.00Pre Close0 Volume0 Open Interest42.00Strike Price0.00Turnover0.00%IV-79.03%PremiumOct 18, 2024Expiry Date18.54Intrinsic Value100Multiplier2DDays to Expiry0.00Extrinsic Value100Contract SizeAmericanOptions Type--Delta--Gamma1.30Leverage Ratio--Theta--Rho--Eff Leverage--Vega
Summit Therapeutics Stock Discussion
After the dual-antibody drug data from Summit Therapeutics (SMMT.US) defeated the "drug king", it was listed as Citigroup's preferred stock and the target price was raised.
i will shot this till $15
Larger Image: tradingview.com...
$Summit Therapeutics (SMMT.US)$
No comment yet